Time-controlled oral delivery systems for colon targeting

Expert Opinion on Drug Delivery

Volumn 3, Issue 5, 2006, Pages 583-597

  Gazzaniga, Andrea ^a   Maroni, Alessandra ^a   Sangalli, Maria Edvige ^a   Zema, Lucia ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

Capsular device; Colon delivery; Erodible coating; Lag phase; Rupturable film; Small intestinal transit time

Indexed keywords

ACETYLSALICYLIC ACID; BICARBONATE; CARBAMAZEPINE; CARBOXYMETHYLCELLULOSE; CITRIC ACID; CROSCARMELLOSE SODIUM; DICLOFENAC; DILTIAZEM; EUDRAGIT; EUDRAGIT RS; GELATIN; HYDROXYPROPYLCELLULOSE; HYDROXYPROPYLMETHYLCELLULOSE; INDOMETACIN; LACTOSE; MACROGOL; MACROGOL 400; MACROGOL 6000; MACROGOL 8000; METOPROLOL FUMARATE; PARACETAMOL; PEPTIDE; PHTHALIC ACID DIETHYL ESTER; POVIDONE; PROTEIN; SODIUM CHLORIDE; SUCCINIC ACID; SULFALAZINE; TERBUTALINE SULFATE; THEOPHYLLINE;

AREA UNDER THE CURVE; CHRONOTHERAPY; COLON; CONTROLLED DRUG RELEASE; CORRELATION COEFFICIENT; DELAYED RELEASE FORMULATION; DISSOLUTION; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG CAPSULE; DRUG DELIVERY SYSTEM; DRUG DOSAGE FORM; DRUG FORMULATION; DRUG SOLUBILITY; DRUG TARGETING; DRUG TOLERABILITY; FILM COATING; HUMAN; INTESTINE ABSORPTION; INTESTINE TRANSIT TIME; MICROCAPSULE; NOCTURNAL ASTHMA; NONHUMAN; OSMOTIC PUMP; PULSATILE DRUG RELEASE; REVIEW; STOMACH EMPTYING; STOMACH PROTECTION; SUSPENSION; SUSTAINED DRUG RELEASE;

ADMINISTRATION, ORAL; ANIMALS; COLON; DIFFUSION; DRUG DELIVERY SYSTEMS; GASTROINTESTINAL TRANSIT; HUMANS; HYDROGEN-ION CONCENTRATION; POLYMERS; TIME FACTORS;

EID: 33748636878     PISSN: 17425247     EISSN: None     Source Type: Journal    
DOI: 10.1517/17425247.3.5.583     Document Type: Review

References (139)

1. GAZZANIGA A, GIORDANO F, SANGALLI ME, ZEMA L: Oral colon-specific drug delivery: design strategies. S.T.P. Pharma Prat. (1994) 4(5):336-343.
2. ASHFORD M, FELL JT: Targeting drugs to the colon: delivery systems for oral administration. J. Drug Target. (1994) 2(3):241-257.
3. RUBINSTEIN A: Approaches and opportunities in colon-specific drug delivery. Crit. Rev. Ther. Drug Car. Syst. (1995) 12(2-3):101-149.
4. VAN DEN MOOTER G, KINGET R: Oral colon-specific drug delivery: a review. Drug Deliv. (1995) 2(2):81-93.
5. WATTS PJ, ILLUM L: Colonic drug delivery. Drug Dev. Ind. Pharm. (1997) 23(9):893-913.
6. KINGET R, KALALA W, VERVOORT L, VAN DEN MOOTER G: Colonic drug delivery. J. Drug Target. (1998) 6(2):129-149.
7. LEOPOLD CS: Coated dosage forms for colon-specific drug delivery. Pharm. Sci. Technol. Today (1999) 2(5):197-204.
8. WILDING I: Site-specific drug delivery in the gastrointestinal tract. Crit. Rev. Ther. Drug Car. Syst. (2000) 17(6):557-620.
9. CHOURASIA MK, JAIN SK: Pharmaceutical approaches to colon targeted drug delivery systems. J. Pharm. Pharm. Sci. (2003) 6(1):33-66.
10. RUBINSTEIN A: Colonic drug delivery. Drug Discov. Today Techn. (2005) 2(1)33-37.
11. BASIT AW: Advances in colonic drug delivery. Drugs (2005) 65(14):1991-2007.
12. VAN DEN MOOTER G: Colon drug delivery. Expert Opin. Drug Deliv. (2006) 3(1):111-125.
13. WIKBERG M, ULMIUS J, RAGNARSSON G: Review article: targeted drug delivery in treatment of intestinal diseases. Aliment. Pbarmacol. Ther. (1997) 11(Suppl. 3);109-115.
14. LAMPRECHT A, STALLMACH A, KAWASHIMA Y, LEHR CM: Carrier systems for the treatment of inflammatory bowel disease. Drugs Future (2002) 27(10):961-971.
15. FRIEND DR: New oral delivery systems for treatment of inflammatory bowel disease. Adv. Drug Deliv. Rev. (2005) 57(2):247-265.
16. KLOTZ U, SCHWAB M: Topical delivery of therapeutic agents in the treatment of inflammatory bowel disease. Adv. Drug Deliv. Rev. (2005) 57(2):267-279.
17. KRISHNAIAH YS, SATYANARAYANA V, KUMAR BD, KARTHIKEYAN RS, BHASKAR P: In vivo pharmacokinetics in human volunteers: oral administered guar gum-based colon-targeted 5-fluorouracil tablets. Eur. J. Pharm. Sci. (2003) 19(5):355-362.
18. LAMPRECHT A, YAMAMOTO H, TAKEUCHI H, KAWASHIMA Y: Microsphere design for the colonic delivery of 5-fluorouracil. J. Control. Release (2003) 90(3):313-322.
19. SINHA VR, MITTAL BR, BHUTANI KK, KUMRIA R: Colonic drug delivery of 5-fluorouracil: an in vitro evaluation. Int. J. Pharm. (2004) 269(1):101-108.
20. ZAMBITO Y, BAGGIANI A, CARELLI V, SERAFINI MF, DI COLO G: Matrices for sites-specific controlled-delivery of 5-fluorouracil to descending colon. J. Control. Release (2005) 102(3):669-677.
21. KRISHNAIAH YS, SATYANARAYANAV, KUMAR BD, KARTHIKEYAN RS: Studies on the development of colon-targeted delivery systems for Celecoxib in the prevention of colorectal cancer. J. Drug Target. (2002) 10(3):247-254.
22. BOURGEOIS S, LAHAM A, BESNARD M, ANDREMONT A, FATTAL E: In vitro and in vivo evaluation of pectin beads for the colon delivery of β-lactamases. J. Drug Target. (2005) 13(5):277-284.
23. SAFFRAN M, KUMAR GS, SAVARIAR C, BURNHAM JC, WILLIAMS F, NECKERS DC: A new approach to the oral administration of insulin and other peptide drugs. Science (1986) 233(4768):1081-1084.
24. RAO SS, RITSCHEL WA. Development and in vitro/in vivo evaluation of a colonic release capsule of vasopressin. Int. J. Pharm. (1992) 86(1):35-41.
25. RUBINSTEIN A, TIROSH B, BALUOM M et al.: The rationale for peptide drug delivery to the colon and the potential of polymeric carriers as effective tools. J. Control. Release (1997) 46(1-2):59-73.
26. MACKAY M, PHILIPS J, HASTWELL J: Peptide drug delivery: colonic and rectal absorption. Adv. Drug Deliv. Rev. (1997) 28(2):253-273.
27. TOZAKI H, KOMOIKE J, TADA C et al.: Chitosan capsules for colon-specific drug delivery: improvement of insulin absorption from the rat colon. J. Pharm. Sci. (1997) 86(9):1016-1021.
28. BOURGEOIS S, HARVEY R, FATTAL E: Polymer colon drug delivery systems and their application to peptides, proteins, and nucleic acids. Am. J. Drug Deliv. (2005) 3(3):171-204.
29. RUBINSTEIN A: Microbially controlled drug delivery to the colon. Biopharm. Drug Dispos. (1990) 11(6):465-475.
30. FRIEND DR: Colon-specific drug delivery. Adv. Drug Deliv. Rev. (1991) 7(1):149-199.
31. SINHA VR, KUMRIA R. Microbially triggered drug delivery to the colon. Eur. J. Pbarm. Sci. (2003) 18(1)3-18.
32. ASHFORD M, FELL JT, ATTWOOD D, WOODHEAD P: An in vitro investigation into the suitability of pH-dependent polymers for colonic targeting. Int. J. Pharm. (1993) 91(2-3);241-245.
33. ASHFORD M, FELL JT, ATTWOOD D, SHARMA H, WOODHEAD P: An in vivo investigation into the suitability of pH dependent polymers for colonic targeting. Int. J. Pharm. (1993) 95(1-3):193-199.
34. FEDORAK RN, BISTRITZ L: Targeted delivery, safety, and efficacy of oral enteric-coated formulations of budesonide. Adv. Drug Deliv. Rev. (2005) 57(2):303-316.
35. EVANS DF, PYE G, BRAMLEY R, CLARK AG, DYSON TJ, HARDCASTLE JD: Measurement of gastrointestinal PH profiles in normal ambulant human subjects. Gut (1988) 29(8):1035-1041.
36. NUGENT SG, KUMAR D, RAMPTON DS, EVANS DF: Intestinal luminal PH in inflammatory bowel disease: possible determinants and implications for therapy with aminosalicylates and other drugs. Gut (2001) 48(4):571-577.
37. LEOPOLD CS, EIKELER D: Eudragit E as coating material for the pH-controlled drug release in the topical treatment of inflammatory bowel disease (IBD). J. Drug Target. (1998) 6(2):85-94.
38. LEOPOLD CS, EIKELER D: Basic coating polymers for the colon-specific drug delivery in inflammatory bowel disease. Drug Dev. Ind. Pharm. (2000) 26(12);1239-1246.
39. HU Z, KIMURA G, MAWATARI S, SHIMOKAWA T, YOSHIKAWA Y, TAKADA K: New preparation method of intestinal pressure-controlled colon delivery capsules by coating machine and evaluation in beagle dogs. J. Control. Release (1998) 56(1-3):293-302.
40. MURAOKA M, HU Z, SHIMOKAWA T et al.: Evaluation of intestinal pressure-controlled colon delivery capsule containing caffeine as a model drug in human volunteers. J. Control. Release (1998) 52(1-2):119-120.
41. HU ZP, MAWATARI S, SHIMOKAWA T et al.: Colon delivery efficiencies of intestinal pressure-controlled colon delivery capsules prepared by a coating machine in human subjects. J. Pharm. Pharmacol. (2000) 52(10):1187-1193.
42. DAVIS SS: The design and evaluation of controlled release systems for the gastro-intestinal tract. J. Control. Release (1985) 2:27-38.
43. DAVIS SS, HARDY JG, FARA LW. Transit of pharmaceutical dosage forms through the small intestine. Gut (1986) 27(8):886-892.
44. BUSSEMER T, OTTO I, BODMEIER R: Pulsatile drug-delivery systems. Crit. Rev. Ther. Drug Carrier Syst. (2001) 18(5):433-458.
45. MARONI A, ZEMA L, CEREA M, SANGALLI ME: Oral pulsatile drug delivery systems. Expert Opin. Drug Deliv. (2005) 2(5):855-871.
46. ISHINO R, YOSHINO H, HIRAKAWA Y, NODA K: Design and preparation of pulsatile release tablet as a new oral drug delivery system. Chem. Pharm. Bull. (1992) 40(11):3036-3041.
47. ISHINO R, YOSHINO H, HIRAKAWA Y, NODA K: Absorption of diltiazem in beagle dog from pulsatile release tablet. Chem. Pharm. Bull. (1992) 40(11):3094-3096.
48. FAN TY, WEI SL, YAN WW, CHEN DB, LI J: An investigation of pulsatile release tablets with ethylcellulose and Eudragit L as film coating materials and cross-linked polyvinylpyrrolidone in the core tablets. J. Control. Release (2001) 77(3):245-251.
49. PEERAPATTANA J, OTSUKA K, OTSUKA M: Time-controlled pulse-drug release from dry-coated wax matrix tablets for colon drug delivery. Biomed. Mater. Eng. (2004) 14(3):293-301.
50. KRÖGEL I, BODMEIER R: Floating or pulsatile drug delivery systems based on coated effervescent cores. Int. J. Pharm. (1999) 187(2):175-184.
51. CHENG G, AN F, ZOU MJ, SUN J, HAO XH, HE YX: Time and pH dependent colon-specific drug delivery for orally administered diclofenac sodium and 5-aminosalicylic acid. World J. Gastroenterol. (2004) 101(12):1769-1774.
52. NIWA K, TAKAYA T, MORIMOTO T, TAKADA K: Preparation and evaluation of a time-controlled release capsule made of ethylcellulose for colon delivery of drugs. J. Drug Target. (1995) 3(2):83-89.
53. MATSUDA KI, TAKAYA T, SHIMOJI F, MURAOKA M, YOSHIKAWA Y, TAKADA K: Effect of food intake on the delivery of fluorescein as a model drug in colon delivery capsule after oral administration to beagle dogs. J. Drug Target. (1996) 4(2):59-67.
54. TAKAYA T, NIWA K, MURAOKA M et al.: Importance of dissolution process on systemic availability of drugs delivered by colon delivery system. J. Control. Release (1998) 50(1-3):111-122.
55. BUSSEMER T, DASHEVSKY A, BODMEIER R: A pulsatile drug delivery system based on rupturable coated hard gelatin capsules. J. Control. Release (2003) 93(3):331-339.
56. DASHEVSKY A, BUSSEMER T, MOHAMAD A, BODMEIER R: Process and formulation variables affecting the performance of a rupturable capsule-based drug delivery system with pulsatile drug release. Drug Dev. Ind. Pharm. (2004) 30(2):171-179.
57. BUSSEMER T, BODMEIER R: Formulation parameters affecting the performance of coated gelatin capsules with pulsatile release profiles. Int. J. Pharm. (2003) 267(1-2):59-68.
58. BUSSEMER T, PEPPAS NA, BODMEIER R: Time-dependent mechanical properties of polymeric coatings used in rupturable pulsatile release dosage forms. Drug Dev. Ind. Pharm. (2003) 29(6):623-630.
59. BUSSEMER T, PEPPAS NA, BODMEIER R: Evaluation of the swelling, hydration and rupturing properties of the swelling layer of a rupturable pulsatile drug delivery system. Eur. J. Pharm. Biopharm. (2003) 56(2):261-270.
60. SUNGTHONGJEEN S, PUTTIPIPATKHACHORN S, PAERATAKUL O, DASHEVSKY A, BODMEIER R: Development of pulsatile release tablets with swelling and rupturable layers. J. Control. Release (2004) 95(2):147-159.
61. UEDA S, HATA T, ASAKURA S, YAMAGUCHI H, KOTANI M, UEDA Y: Development of a novel drug release system, time-controlled explosion system (TES). I. Concept and design. J. Drug Target. (1994) 2(1):35-44.
62. UEDA S, YAMAGUCHI H, KOTANI M et al.: Development of a novel drug release system, time-controlled explosion system (TES). II. Design of multiparticulate TES and in vitro drug release properties. Chem. Pharm. Bull (1994) 42(2):359-363.
63. UEDA S, IBUKI R, KIMURA S et al.: Development of a novel drug release system, time-controlled explosion system (TES). III. Relation between lag time and membrane thickness. Chem. Pharm. Bull. (1994) 42(2):364-367.
64. HATA T, SHIMAZAKI Y, KAGAYAMA A, TAMURA S, UEDA S: Development of a novel drug release system, time-controlled explosion system (TES). V. Animal pharmacodynamic study and human bioavailability study. Int. J. Pharm. (1994) 110(1):1-7.
65. MURATA S, UEDA S, SHIMOJO F, TOKUNAGA Y, HATA T, OHNISHI N: In vivo performance of time-controlled explosion system (TES) in GI physiology regulated dogs. Int. J. Pharm. (1998) 161(2):161-168.
66. SCHULTZ P, KLEINEBUDDE P: A new multiparticulate delayed release system. Part I: dissolution properties and release mechanism. J. Control. Release (1997) 47(2):181-189.
67. SCHULTZ P, THO I, KLEINEBUDDE P: A new multiparticulate delayed release system. Part II: coating formulation and properties of free films. J. Control. Release (1997) 47(2):191-199.
68. ARIMOTO M, ICHIKAWA H, FUKUMORI Y. Microencapsulation of water-soluble macromolecules with acrylic terpolymers by the Wurster coating process for colon-specific drug delivery. Powder Tech. (2004) 141(3):177-186.
69. MAFFIONE G, IAMARTINO P, GUGLIELMINI G, GAZZANIGA A; High-viscosity HPMC as a film-coating agent. Drug Dev. Ind. Pharm, (1993) 19(16):2043-2053.
70. GAZZANIGA A, SANGALLI ME, GIORDANO F: Oral Chronotopic® drug delivery systems: achievement of time and/or site specificity. Eur. J. Pharm. Biopharm. (1994) 40(4):246-250.
71. GAZZANIGA A, IAMARTINO P, MAFFIONE G, SANGALLI ME: Oral delayed-release system for colonic specific delivery. Int. J. Pharm. (1994) 108(1):77-83.
72. GAZZANIGA A, BUSETTI C, MORO L, SANGALLI ME, GIORDANO F: Time-dependent oral delivery systems for colon targeting. S.T.P. Pharma Sci. (1995) 5(1):83-88.
73. SANGALLI ME, MARONI A, ZEMA L, BUSETTI C, GIORDANO F, GAZZANIGA A: In vitro and in vivo evaluation of an oral system for time and/or site-specific drug delivery. J. Control. Release (2001) 73(1):103-110.
74. SANGALLI ME, MARONI A, FOPPOLI A, ZEMA L, GIORDANO F, GAZZANIGA A: Different HPMC viscosity grades as coating agents for an oral time and/ or site-controlled delivery system: A study on process parameters and in vitro performances. Eur. J. Pharm. Sci. (2004) 22(5):469-476.
75. SANGALLI ME, MARONI A, CEREA M, FOPPOLI A, GIORDANO F, GAZZANIGA A: Pharmacoscintigraphic investigation into the performances of a 5-ASA-containing oral system for colon targeting. Proceed. Int. Meet. Pharm. Biopharm. Pharm. Tech. (2004) 1:815-816.
76. MARONI A, SANGALLI ME, CEREA M, BUSETTI C, GIORDANO F, GAZZANIGA A. Low viscosity HPMC coating of soft- and hard-gelatin capsules for delayed and colonic release: preliminary investigations on process parameters and in vitro release performances. Proceed. Int. Symp. Control. Rel. Bioact. Mater. (1999) 26:885-886.
77. COUVREUR P, PUISIEUX F: Nano- and micro-partides for the delivery of polypeprides and proteins. Adv. Drug Deliv. Rev. (1993) 10(2):141-162.
78. CARINO GP, MATHIOWITZ E: Oral insulin delivery. Adv. Drug Dev. Rev. (1999) 35(2-3):249-257.
79. JUNG T, KAMM W, BREITENBACH A, KAISERLING E, XIAO JY, KISSEL T: Biodegradable nanoparticles for oral delivery of peptides: is there a role for polymers to affect mucosal uptake? Eur. J. Pharm. Biopharm. (2000) 50(1):147-160.
80. PIRULLI V, CEREA M, MARONI A, ZEMA L, GIORDANO F, GAZZANIGA A: HPMC-coating of tablets in tangential-spray rotary fluid bed for the achievement of an oral time and/or site-controlled delivery system. Proceed. Int. Symp. Control. Rel. Bioact. Mater. (2004) 31:391-392.
81. CEREA M, SERRATONI M, MARONI A et al.: Preparation of an oral time-controlled delivery system by HPMC powder-layering. Transactions ofthe Annual Meeting of Controlled Release Society (2006) 33:882.
82. QI M, WANG P, WU D: A novel pH and time dependent system for colonic drug delivery. Drug Dev. Ind. Pharm. (2003) 29(6):661-667.
83. CAO QR, CHOI HG, KIM DC, LEE BJ: Release behavior and photo-image of nifedipine tablet coated with high viscosity grade hydroxypropylmethylcellulose: effect of coating conditions. Int. J. Pharm. (2004) 274(1-2):107-117.
84. FUKUI E, UEMURA K, KOBAYASHI M: Studies on applicability of press-coated tablets using hydroxypropylcellulose (HPC) in the outer shell for timed-release preparations. J. Control. Release (2000) 68(2):215-223.
85. FUKUI E, MIYAMURA N, UEMURA K. KOBAYASHI M: Preparation of enteric coated timed-release press-coated tablets and evaluation of their function by in vitro and in vivo tests for colon targeting. Int. J. Pharm. (2000) 204(1-2):7-15.
86. FUKUI E, MIYAMURA N, YONEYAMA T, KOBAYASHI M: Drug release from and mechanical properties of press-coated tablets with hydroxypropylmethylcellulose acetate succinate and plasticizers in the outer shell. Int. J. Pharm. (2001) 217(1-2):33-43.
87. FUKUI E, MIYAMURA N, KOBAYASHI M: An in vitro investigation ofthe suitability of press-coated tablets with hydroxypropylmethylcellulose acetate succinate (HPMCAS) and hydrophobic additives in the outer shell for colon targeting. J. Control. Release (2001) 70(1-2):97-107.
88. FUKUI E, MIYAMURA N, KOBAYASHI M: Effect of magnesium stearate or calcium stearate as additives on dissolution profiles of diltiazem hydrochloride from press-coated tablets with hydroxypropylmethylcellulose acetate succinate in the outer shell. Int. J. Pharm. (2001) 216(1-2):137-146.
89. VANDELLI MA, LEO E, FORNI F, BERNABEI MT: In vitro evaluation of a potential colonic delivery system that releases drug after a controllable lag-time. Eur. J. Pharm. Biopharm. (1996) 43(2):148-151.
90. MATSUO M, NAKAMURA C, ARIMORI K, NAKANO M: Evaluation of hydroxyethylcellulose as a hydrophilic swellable material for delayed-release tablets. Chem. Pharm. Bull. (1995) 43(2):311-314.
91. MATSUO M, ARIMORI K, NAKAMURA C, NAKANO M: Delayed-release tablets using hydroxyethylcellulose as a gel-forming matrix. Int. J. Pharm. (1996) 138(2):225-235.
92. SAWADA T, SAKO K, FUKUI M, YOKOHAMA S, HAYASHI M: A new index, the core erosion ratio, of compression-coated timed-release tablets predicts the bioavailability of acetaminophen. Int. J. Pharm. (2003) 265(1-2):55-63.
93. TAKEUCHI H, YASUJI T, YAMAMOTO H, KAWASHIMA Y: Spray-dried lactose composite particles containing an ion complex of alginate-chitosan for designing a dry-coated tablet having a time-controlled releasing function. Pharm. Res. (2000) 17(1)94-99.
94. POZZI F, FURLANI P, GAZZANIGA A, DAVIS SS, WILDING IR: The TimeClock* system: a new oral dosage form for fast and complete release of drug after a predetermined lag time. J. Control. Release (1994) 31(1):99-108.
95. WILDING IR, DAVIS SS, POZZI E, FURLANI P, GAZZANIGA A: Enteric coated timed release systems for colonic targeting. Int. J. Pharm. (1994) 111(1):99-102.
96. STEED KP, HOOPER G, MONTI N, STROLIN BENEDETTI M, FORNASINI G, WILDING IR: The use of pharmacoscintigraphy to focus the development strategy for a novel 5-ASA colon targeting system ('Time Clock®' system). J. Control. Release (1997) 49(2-3):115-122.
97. ISHIBASHI T, HATANO H, KOBAYASHI M, MIZOBE M, YOSHINO H: Design and evaluation of a new capsule-type dosage form for colon-target delivery of drugs. Int. J. Pharm. (1998) 168(1):31-40.
98. ISHIBASHI T, PITCAIRN GR, YOSHINO H, MIZOBE M, WILDING IR: Scintigraphic evaluation of a new capsule-type colon specific drug delivery system in healthy volunteers. J. Pharm. Sci. (1998) 87(5):531-535.
99. ISHIBASHI T, HATANO H, KOBAYASHI M, MIZOBE M, YOSHINO H: In vivo drug release behavior in dogs from a new colon-targeted delivery system. J. Control. Release (1999) 57(1):45-53.
100. ISHIBASHI T, IKEGAMI K, KUBO H, KOBAYASHI M, MIZOBE M, YOSHINO H: Evaluation of colonic absorbability of drugs in dogs using a novel colon-targeted delivery capsule (CTDC). J. Control. Release (1999) 59(3):361-376.
101. ALVAREZ-FUENTES J, FERNANDEZ-AREVALO M, GONZALEZ-RODRIGUEZ ML, CIRRI M, MURA P: Development of enteric-coated timed-release matrix tablets for colon targeting. J. Drug Target. (2004) 12(9-10):607-612.
102. KLOKKERS-BETHKE K, FISCHER W: Development of a multiple unit drug delivery system for positioned release in the gastrointestinal tract. J. Control. Release (1991) 15(2):105-112.
103. XING L, DAWEI C, LIPING X, RONGQING Z: Oral colon-specific drug delivery for bee venom peptide: development of a coated calcium alginate gel beads-entrapped liposome. J. Control. Release (2003) 93(3):293-300.
104. GUPTA VK, BECKERT TE, PRICE JC: A novel pH- and time-based multi-unit potential colonic drug delivery system. I. Development. Int. J. Pharm. (2001) 213(1-2):83-91.
105. GUPTA VK, ASSMUS MW, BECKERT TE, PRICE JC: A novel pH-and time-based multi-unit potential colonic drug delivery system. II. Optimization of multiple response variables. Int. J. Pharm. (2001) 213(1-2):93-102.
106. RUDOLPH MW, KLEIN S, BECKERT TE, PETEREIT H, DRESSMAN JB: A new 5-aminosalicilyc acid multi-unit dosage form for the therapy of ulcerative colitis. Eur. J. Pharm. Biopharm. (2001) 51(3):183-190.
107. BOTT C, RUDOLPH MW, SCHNEIDER AR et al.: In vivo evaluation of a novel pH- and time-based multiunit colonic drug delivery system. Aliment. Pharmacol. Ther. (2004) 20(3):347-353.
108. GONZALEZ-RODRIGUEZ ML, FERNANDEZ-HERVAS MJ, CARABALLO I, RABASCO AM: Design and evaluation of a new central core matrix tablet. Int. J. Pharm. (1997) 146(2):175-180.
109. GONZALEZ-RODRIGUEZ ML, PEREZ-MARTINEZ JI, MERINO S, FINI A, RABASCO AM: Channeling agent and drug release from a central core matrix tablet. Drug Dev. Ind. Pharm. (2001) 27(5):439-446.
110. GONZALEZ-RODRIGUEZ ML, MAESTRELLI F, MURA P, RABASCO AM: In vitro release of sodium diclofenac from a central core matrix tablet aimed for colonic drug delivery. Eur. J. Pharm. Sci. (2003) 20(1):125-131.
111. NARISAWA S, NAGATA M, DANYOSHI C et al.: An organic acid-induced sigmoidal release system for oral controlled-release preparations. Pharm. Res. (1994) 11(1):111-116.
112. NARISAWA S, NAGATA M, ITO T, YOSHINO H, HIRAKAWA Y, NODA K: Drug release behavior in gastrointestinal tract of beagle dogs from multiple unit type rate-controlled or time-controlled release preparations coated with insoluble polymer-based film. J. Control. Release (1995) 33(2):253-260.
113. NARISAWA S, NAGATA M, HIRAKAWA Y, KOBAYASHI M, YOSHINO H: An organic acid-induced sigmoidal release system for oral controlled-release preparations. 2. Permeability enhancement of Eudragit RS coating led by the physicochemical interactions with organic acid. J. Pharm. Sci. (1996) 85(2):184-188.
114. NARISAWA S, NAGATA M, HIRAKAWA Y, KOBAYASHI M, YOSHINO H: An organic acid-induced sigmoidal release system for oral controlled-released preparations. III. Elucidation of the anomalous drug release behaviour through osmotic pumping mechanism. Int. J. Pharm. (1997) 148(1):85-91.
115. KAO CC, CHEN SC, SHEU MT: Lag time method to delay drug release to various sites in the gastrointestinal tract. J. Control. Release (1997) 44(2-3):263-270.
116. WILDING IR, DAVIS SS, BAKHSHAEE M, STEVENS HN, SPARROW RA, BRENNAN J: Gastrointestinal transit and systemic absorption of captopril from a pulsed-release formulation. Pharm. Res. (1992) 9(5):654-657.
117. BINNS J, STEVENS HN, MCEWEN J et al.: The tolerability of multiple oral doses of Pulsincap™ capsules in healthy volunteers. J. Control. Release (1996) 38(2-3):151-158.
118. WILSON CG, BAKHSHAEE M, STEVENS HN et al.: Evaluation of a gastro-resistant pulsed release delivery system (Pulsincap) in humans. Drug Deliv. (1997) 4(3):201-206.
119. HEBDEN JM, WILSON CG, SPILLER RC et al.: Regional differences in quinine absorption from the undisturbed human colon assessed using a timed release delivery system. Pharm. Res. (1999) 16(7):1087-1092.
120. HEBDEN JM, GILCHRIST PJ, PERKINS AC, WILSON CG, SPILLER RC: Stool water content and colonic drug absorption: contrasting effects of lactulose and codeine. Pharm. Res. (1999) 16(8):1254-1259.
121. STEVENS HN, WILSON CG, WELLING PC et al.: Evaluation of Pulsincap™ to provide regional delivery of dofetilide to the human GI tract. Int. J. Pharm. (2002) 236(1-2):27-34.
122. ROSS AC, MACRAE RJ, WALTHER M, STEVENS HN: Chronopharmaceutical drug delivery from a pulsatile capsule device based on programmable erosion. J. Pharm. Pharmacol. (2000) 52(8):903-909.
123. MCCONVILLE JT, ROSS AC, CHAMBERS AR, SMITH G, FLORENCE AJ, STEVENS HN: The effect of wet granulation on the erosion behaviour of an HPMC-lactose tablet, used as a rate-controlling component in a pulsatile drug delivery capsule formulation. Eur. J. Pharm. Biopharm. (2004) 57(3):541-549.
124. SUTCH JC, ROSS AC, KÖCKENBERGER W et al.: Investigating the coating-dependent release mechanism of a pulsatile capsule using NMR microscopy. J. Control. Release (2003) 92(3):341-347.
125. MCCONVILLE JT, ROSS AC, FLORENCE AJ, STEVENS HN: Erosion characteristics of an erodible tablet incorporated in a time-delayed capsule device. Drug Dev. Ind. Pharm. (2005) 31(1):79-89.
126. KRÖGEL I, BODMEIER R: Pulsatile drug release from an insoluble capsule body controlled by an erodible plug. Pharm. Res. (1998) 15(3):474-481.
127. KRÖGEL I, BODMEIER R: Evaluation of an enzyme-containing capsular shaped pulsatile drug delivery system. Pharm. Res. (1999) 16(9):1424-1429.
128. GOHEL MC, SUMITRA GM: Modulation of active pharmaceutical material release from a novel 'tablet in capsule system' containing an effervescent blend. J. Control. Release (2002) 79(1-3):157-164.
129. CRISON JR, SIERSMA PR, TAYLOR MD, AMIDON GL: Programmable oral release technology, PortSystems®: a novel dosage form for time and site specific oral drug delivery. Proceed. Int. Symp. Control. Rel. Bioact. Mater. (1995) 22:278-279.
130. CRISON JR, SIERSMA PR, AMIDON GL: A novel programmable oral release technology for delivering drugs: human feasibility testing using gamma scintigraphy. Proceed. Int. Symp. Control. Rel. Bioact. Mater. (1996) 23:51-52.
131. LEE WW, O'MAHONY B, BAR-SHALOM D et al.: Scintigraphic characterisation of a novel injection-moulded dosage form. Proceed. Int. Symp. Control. Rel. Bioact. Mater. (2000) 27:1288-1289.
132. O'MAHONY B, KÖBERLE M, WILSON CG et al.: Scintigraphic assessment of a system (Egalet®) for pulsatile peptide delivery in man. Proceed. Int. Symp. Control. Rel. Bioact. Mater. (2001) 28:983-984.
133. GUPTA SK, ATKINSON L, THEEUWES F, WONG P, GILBERT PJ, LONGSTRETH J: Pharmacokinetics of verapamil from an osmotic system with delayed onset. Eur. J. Pharm. Biopharm. (1996) 42(1):74-81.
134. CHACKO A, SZAZ KF, HOWARD J, CUMMINGS JH: Non-invasive method for delivery of tracer substances or small quantities of other materials to the colon. Gut (1990) 31(1):106-110.
135. QUADROS E, CASSIDY J, HIRSCHBERG Y, OBERLE R, CARR J, SAVASTANO L: Evaluation of a novel colonic delivery device in vivo. S.T.P. Pharma Sci. (1995) 5(1):77-82.
136. THEEUWES F: Elementary osmotic pump. J. Pharm. Sci. (1975) 64(12):1987-1991.
137. ZHANG Y, ZHANG Z, WU F: A novel pulsed-release system based on swelling and osmotic pumping mechanism. J. Control. Release (2003) 89(1):47-55.
138. KLEIN S, STEIN J, DRESSMAN J: Site-specific delivery of anti-inflammatory drugs in the gastrointestinal tract: an in-vitro release model. J. Pharm. Pharmacol. (2005) 57(6):709-719.
139. DAVIS SS, WILDING IR: Oral drug absorption studies: the best model for man is man! Drug Discov. Today (2001) 6(3):127-128.